- Corporate Officers - N
- Nodelman Oleg
Insider Trading History of Nodelman Oleg
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nodelman Oleg since 2021.
This trader's CIK number is 1454385.
At the time of last reporting, Nodelman Oleg was the Officer of Aktis Oncology, Inc.. (stock ticker symbol AKTS).
Also see all insider trading activities at Aktis Oncology, Inc..
Note that in the past
NODELMAN OLEG also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zymeworks Inc. (ZYME) by Nodelman Oleg
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ZYME | 2,163,747 | $26,071,681 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Anaptysbio, Inc (ANAB) by Nodelman Oleg
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ANAB | 668,237 | $14,453,966 | 668,237 | $14,453,966 | 0 | $0 |
| 2021 | ANAB | 368,800 | $8,627,663 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aktis Oncology, Inc. (AKTS) by Nodelman Oleg
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | AKTS | 2,222,222 | $39,999,996 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Nodelman Oleg:
1. Zymeworks Inc. (ZYME)
2. Anaptysbio, Inc (ANAB)
3. Aktis Oncology, Inc. (AKTS)
Table 1. Insider trading of Zymeworks Inc. (ZYME) by Nodelman Oleg
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-19 | ZYME | Buy | 5,919 | 11.78 | 69,737 |
| 2025-05-15 | ZYME | Buy | 49,502 | 11.43 | 565,857 |
| 2025-04-16 | ZYME | Buy | 73,953 | 11.16 | 825,611 |
| 2025-04-17 | ZYME | Buy | 54,760 | 11.52 | 630,835 |
| 2025-04-03 | ZYME | Buy | 120,770 | 11.84 | 1,430,158 |
| 2025-04-04 | ZYME | Buy | 196,438 | 11.17 | 2,193,819 |
| 2025-03-31 | ZYME | Buy | 4,397 | 11.75 | 51,660 |
| 2025-04-02 | ZYME | Buy | 74,360 | 11.85 | 881,017 |
| 2025-04-01 | ZYME | Buy | 48,658 | 11.60 | 564,627 |
| 2025-03-25 | ZYME | Buy | 53,501 | 12.90 | 690,430 |
| 2025-03-26 | ZYME | Buy | 43,848 | 12.24 | 536,874 |
| 2025-03-20 | ZYME | Buy | 73,476 | 12.93 | 949,897 |
| 2025-03-21 | ZYME | Buy | 31,033 | 12.78 | 396,508 |
| 2025-03-24 | ZYME | Buy | 22,689 | 13.08 | 296,840 |
| 2025-03-17 | ZYME | Buy | 56,277 | 12.23 | 688,492 |
| 2025-03-18 | ZYME | Buy | 113,880 | 12.65 | 1,440,809 |
| 2025-03-19 | ZYME | Buy | 58,306 | 12.64 | 737,221 |
| 2025-03-13 | ZYME | Buy | 468,356 | 12.48 | 5,847,424 |
| 2025-03-11 | ZYME | Buy | 320,690 | 11.49 | 3,686,010 |
| 2025-03-12 | ZYME | Buy | 292,934 | 12.25 | 3,587,855 |
Table 2. Insider trading of Anaptysbio, Inc (ANAB) by Nodelman Oleg
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-05 | ANAB | Sale | 668,237 | 21.63 | 14,453,966 |
| 2022-05-05 | ANAB | Buy | 668,237 | 21.63 | 14,453,966 |
| 2021-04-30 | ANAB | Buy | 35,700 | 23.16 | 826,812 |
| 2021-05-03 | ANAB | Buy | 20,800 | 23.31 | 484,868 |
| 2021-05-04 | ANAB | Buy | 165,000 | 23.25 | 3,835,755 |
| 2021-04-23 | ANAB | Buy | 99,600 | 23.54 | 2,344,285 |
| 2021-04-26 | ANAB | Buy | 13,900 | 23.80 | 330,861 |
| 2021-04-27 | ANAB | Buy | 33,800 | 23.82 | 805,082 |
Table 3. Insider trading of Aktis Oncology, Inc. (AKTS) by Nodelman Oleg
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-01-12 | AKTS | Buy | 2,222,222 | 18.00 | 39,999,996 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nodelman Oleg
(Officer of Aktis Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.